Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Prat Vidal, Cristina ^a   Gálvez Montón, Carolina ^a   Nonell, Lara ^b   Puigdecanet, Eulàlia ^b   Astier, Laura ^a   Solé, Francesc ^b,c   Bayes Genis, Antoni ^a,d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; PROTEIN BID; RNA; SMAD1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA3;

ACVR2B GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BID GENE; BMP2 GENE; BMPR1A GENE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; HEART FAILURE; HEART INFARCTION; LMNA GENE; MICROARRAY ANALYSIS; MOLECULAR DYNAMICS; NFKBIA GENE; NONHUMAN; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA PROBE; SEQUENCE ANALYSIS; SMAD1 GENE; SWINE; SYSTEMIC SCLEROSIS; TGFB3 GENE; TNFRSF1A GENE; TP53 GENE;

ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MYOCARDIAL INFARCTION; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; SWINE; TIME FACTORS;

ANIMALIA; SUIDAE; SUS;

EID: 84872858194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054785     Document Type: Article

References (59)

1. Fishbein MC, Maclean D, Maroko PR, (1978) The histopathologic evolution of myocardial infarction. Chest 73: 843-849.
2. Pfeffer MA, Braunwald E, (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172.
3. Anversa P, Li P, Zhang X, Olivetti G, Capasso JM, (1993) Ischaemic myocardial injury and ventricular remodelling. Cardiovasc Res 27: 145-157.
4. Sutton MG, Sharpe N, (2000) Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988.
5. Stanton LW, Garrard LJ, Damm D, Garrick BL, Lam A, et al. (2000) Altered patterns of gene expression in response to myocardial infarction. Circ Res 86: 939-945.
6. Harpster MH, Bandyopadhyay S, Thomas DP, Ivanov PS, Keele JA, et al. (2006) Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome 17: 701-715.
7. Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, et al. (2008) Sex-specific pathways in early cardiac response to pressure overload in mice. J Mol Med 86: 1013-1024.
8. Mudd JO, Kass DA, (2008) Tackling heart failure in the twenty-first century. Nature 451: 919-928.
9. Haghighi K, Kolokathis F, Pater L, Lynch RA, Asahi M, et al. (2003) Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 111: 869-876.
10. Ahmed SH, Rakhawy MT, Abdalla A, Assaad EI, (1978) The comparative anatomy of the blood supply of cardiac ventricles in the albino rat and guinea-pig. J Anat 126: 51-57.
11. Icardo JM, Colvee E, (2001) Origin and course of the coronary arteries in normal mice and in iv/iv mice. J Anat 199: 473-482.
12. Weaver ME, Pantely GA, Bristow JD, Ladley HD, (1986) A quantitative study of the anatomy and distribution of coronary arteries in swine in comparison with other animals and man. Cardiovasc Res 20: 907-917.
13. Duggan DJ, Bittner M, Chen Y, Meltzer P, Trent JM, (1999) Expression profiling using cDNA microarrays. Nat Genet 21: 10-14.
14. Galvez-Monton C, Prat-Vidal C, Roura S, Farre J, Soler-Botija C, et al. (2011) Transposition of a pericardial-derived vascular adipose flap for myocardial salvage after infarct. Cardiovasc Res 91: 659-667.
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
16. Smyth GK, (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
17. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57: 289-300.
18. Tsai S, Cassady JP, Freking BA, Nonneman DJ, Rohrer GA, et al. (2006) Annotation of the Affymetrix porcine genome microarray. Anim Genet 37: 423-424.
19. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
20. Alexa A, Rahnenfuhrer J, Lengauer T, (2006) Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22: 1600-1607.
21. Barrans JD, Allen PD, Stamatiou D, Dzau VJ, Liew CC, (2002) Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 160: 2035-2043.
22. Tan FL, Moravec CS, Li J, Apperson-Hansen C, McCarthy PM, et al. (2002) The gene expression fingerprint of human heart failure. Proc Natl Acad Sci U S A 99: 11387-11392.
23. Hwang JJ, Allen PD, Tseng GC, Lam CW, Fananapazir L, et al. (2002) Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics 10: 31-44.
24. Chen Y, Park S, Li Y, Missov E, Hou M, et al. (2003) Alterations of gene expression in failing myocardium following left ventricular assist device support. Physiol Genomics 14: 251-260.
25. Margulies KB, Matiwala S, Cornejo C, Olsen H, Craven WA, et al. (2005) Mixed messages: transcription patterns in failing and recovering human myocardium. Circ Res 96: 592-599.
26. Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, et al. (2004) Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation 110: 3444-3451.
27. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, et al. (2005) Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics 21: 299-307.
28. Blaxall BC, Tschannen-Moran BM, Milano CA, Koch WJ, (2003) Differential gene expression and genomic patient stratification following left ventricular assist device support. J Am Coll Cardiol 41: 1096-1106.
29. Steenman M, Chen YW, Le Cunff M, Lamirault G, Varro A, et al. (2003) Transcriptomal analysis of failing and nonfailing human hearts. Physiol Genomics 12: 97-112.
30. Kuster DW, Merkus D, Kremer A, van Ijcken WF, de Beer VJ, et al. (2011) Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach. Basic Res Cardiol 106: 1269-1281.
31. Tschöpe C, Heringer-Walther S, Koch M, Spillmann F, Wendorf M, et al. (2000) Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J Hypertens 18: 223-228.
32. Sandmann S, Yu M, Kaschina E, Blume A, Bouzinova E, et al. (2001) Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction. J Am Coll Cardiol 37: 2154-2165.
33. Chugh SS, Whitesel S, Turner M, Roberts CT Jr, Nagalla SR, (2003) Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model. Cardiovasc Res 57: 477-485.
34. Potter LR, Abbey-Hosch S, Dickey DM, (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72.
35. Lopez MJ, Wong SK, Kishimoto I, Dubois S, Mach V, et al. (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68.
36. Oliver PM, Fox JE, Kim R, Rockman HA, Kim HS, et al. (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci U S A 94: 14730-14735.
37. Holtwick R, van Eickels M, Skryabin BV, Baba HA, Bubikat A, et al. (2003) Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. J Clin Invest 111: 1399-1407.
38. Manabe I, Shindo T, Nagai R, (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91: 1103-1113.
39. Kupfahl C, Pink D, Friedrich K, Zurbrugg HR, Neuss M, et al. (2000) Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res 46: 463-475.
40. Rosenkranz S, Flesch M, Amann K, Haeuseler C, Kilter H, et al. (2002) Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1). Am J Physiol Heart Circ Physiol 283: H1253-1262.
41. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, et al. (2001) Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 280: H1782-1792.
42. Zhang X, Chai J, Azhar G, Sheridan P, Borras AM, et al. (2001) Early postnatal cardiac changes and premature death in transgenic mice overexpressing a mutant form of serum response factor. J Biol Chem 276: 40033-40040.
43. Sehl PD, Tai JT, Hillan KJ, Brown LA, Goddard A, et al. (2000) Application of cDNA microarrays in determining molecular phenotype in cardiac growth, development, and response to injury. Circulation 101: 1990-1999.
44. Lyn D, Liu X, Bennett NA, Emmett NL, (2000) Gene expression profile in mouse myocardium after ischemia. Physiol Genomics 2: 93-100.
45. Jin H, Yang R, Awad TA, Wang F, Li W, et al. (2001) Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103: 736-742.
46. Elmore S, (2007) Apoptosis: A review of programmed cell death. Toxicol Pathol 35: 495-516.
47. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, et al. (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23: 2861-2874.
48. Gross A, Yin XM, Wang K, Wei MC, Jockel J, et al. (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274: 1156-1163.
49. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, et al. (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901.
50. Hochhauser E, Cheporko Y, Yasovich N, Pinchas L, Offen D, et al. (2007) Bax deficiency reduces infarct size and improves long-term function after myocardial infarction. Cell Biochem Biophys 47: 11-20.
51. Barnes RM, Firulli AB, (2009) A twist of insight- the role of Twist-family bHLH factors in development. Int J Dev Biol 53: 909-924.
52. Firulli AB, (2003) A HANDful of questions: the molecular biology of the heart and neural crest derivatives (HAND)-subclass of basic helix-loop-helix transcription factors. Gene 312: 27-40.
53. Massari ME, Murre C, (2000) Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 20: 429-440.
54. Lu S, Nie J, Luan Q, Feng Q, Xiao Q, et al. (2011) Phosphorylation of the Twist1-family basic helix-loop-helix transcription factors is involved in pathological cardiac remodeling. PloS one 6: e19251.
55. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, et al. (2004) Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 10: 1245-1250.
56. Rajeevan MS, Vernon SD, Taysavang N, Unger ER, (2001) Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 3: 26-31.
57. Bhatnagar S, Panguluri SK, Kumar A, (2012) Gene profiling studies in skeletal muscle by quantitative real-time polymerase chain reaction assay. Methods Mol Biol 798: 311-324.
58. Panguluri SK, Kakar SS, (2012) Using quantitative real-time reverse transcriptase polymerase chain reaction to validate gene regulation by PTTG. Methods Mol Biol 815: 131-145.
59. Peterson JT, Li H, Dillon L, Bryant JW, (2000) Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46: 307-315.